221 related articles for article (PubMed ID: 34615637)
1. Does biologic therapy impact the development of PsA among patients with psoriasis?
Meer E; Merola JF; Fitzsimmons R; Love TJ; Wang S; Shin D; Chen Y; Xie S; Choi H; Zhang Y; Scher JU; Ritchlin CT; Gelfand JM; Ogdie A
Ann Rheum Dis; 2022 Jan; 81(1):80-86. PubMed ID: 34615637
[TBL] [Abstract][Full Text] [Related]
2. Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis.
Gisondi P; Bellinato F; Targher G; Idolazzi L; Girolomoni G
Ann Rheum Dis; 2022 Jan; 81(1):68-73. PubMed ID: 34144965
[TBL] [Abstract][Full Text] [Related]
3. Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis.
Wu JJ; Pelletier C; Ung B; Tian M; Khilfeh I; Curtis JR
Adv Ther; 2020 May; 37(5):2098-2115. PubMed ID: 32141018
[TBL] [Abstract][Full Text] [Related]
4. Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis.
Acosta Felquer ML; LoGiudice L; Galimberti ML; Rosa J; Mazzuoccolo L; Soriano ER
Ann Rheum Dis; 2022 Jan; 81(1):74-79. PubMed ID: 34281904
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Psoriatic Arthritis Among Patients Receiving Biologic Treatments for Psoriasis: A Nested Case-Control Study.
Rosenthal YS; Schwartz N; Sagy I; Pavlovsky L
Arthritis Rheumatol; 2022 Feb; 74(2):237-243. PubMed ID: 34423909
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis.
Bissonnette R; Kerdel F; Naldi L; Papp K; Galindo C; Langholff W; Tang KL; Szapary P; Fakharzadeh S; Srivastava B; Goyal K; Gottlieb AB
J Drugs Dermatol; 2017 Oct; 16(10):1002-1013. PubMed ID: 29036254
[TBL] [Abstract][Full Text] [Related]
7. Real-world trends in biologic, oral systemic, and phototherapy in US patients with psoriasis or psoriatic arthritis.
Singh P; Silverberg JI
J Am Acad Dermatol; 2020 Jul; 83(1):256-257. PubMed ID: 32004649
[No Abstract] [Full Text] [Related]
8. Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis.
Feldman SR; Zhao Y; Shi L; Tran MH
J Manag Care Spec Pharm; 2015 Oct; 21(10):874-88. PubMed ID: 26402388
[TBL] [Abstract][Full Text] [Related]
9. From Psoriasis to Psoriatic Arthritis: Decoding the Impact of Treatment Modalities on the Prevention of Psoriatic Arthritis.
Watad A; Zabotti A; Patt YS; Gendelman O; Dotan A; Ben-Shabat N; Fisher L; McGonagle D; Amital H
Rheumatol Ther; 2024 Jun; ():. PubMed ID: 38847993
[TBL] [Abstract][Full Text] [Related]
10. The risk of treated anxiety and treated depression among patients with psoriasis and psoriatic arthritis treated with apremilast compared to biologics, DMARDs and corticosteroids: a cohort study in the United States MarketScan database.
Vasilakis-Scaramozza C; Persson R; Hagberg KW; Jick S
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1755-1763. PubMed ID: 31981426
[TBL] [Abstract][Full Text] [Related]
11. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey.
van de Kerkhof PC; Reich K; Kavanaugh A; Bachelez H; Barker J; Girolomoni G; Langley RG; Paul CF; Puig L; Lebwohl MG
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):2002-10. PubMed ID: 25885420
[TBL] [Abstract][Full Text] [Related]
12. US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.
Lebwohl MG; Kavanaugh A; Armstrong AW; Van Voorhees AS
Am J Clin Dermatol; 2016 Feb; 17(1):87-97. PubMed ID: 26718712
[TBL] [Abstract][Full Text] [Related]
13. Combining traditional systemic and biologic therapies for psoriasis.
Heffernan MP
Semin Cutan Med Surg; 2010 Mar; 29(1):67-9. PubMed ID: 20430311
[TBL] [Abstract][Full Text] [Related]
14. Psoriatic arthritis and psoriasis: need for a multidisciplinary approach.
Qureshi AA; Husni ME; Mody E
Semin Cutan Med Surg; 2005 Mar; 24(1):46-51. PubMed ID: 15900798
[TBL] [Abstract][Full Text] [Related]
15. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
[TBL] [Abstract][Full Text] [Related]
16. Evidence that systemic therapies for psoriasis may reduce psoriatic arthritis occurrence.
Solmaz D; Ehlebracht A; Karsh J; Bakirci S; McGonagle D; Aydin SZ
Clin Exp Rheumatol; 2020; 38(2):257-261. PubMed ID: 31287403
[TBL] [Abstract][Full Text] [Related]
17. Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR).
Strober B; Gooderham M; de Jong EMGJ; Kimball AB; Langley RG; Lakdawala N; Goyal K; Lawson F; Langholff W; Hopkins L; Fakharzadeh S; Srivastava B; Menter A
J Am Acad Dermatol; 2018 Jan; 78(1):70-80. PubMed ID: 29102053
[TBL] [Abstract][Full Text] [Related]
18. Serious infection risk in children with psoriasis on systemic treatment: A propensity score-matched population-based study.
Schneeweiss MC; Huang JT; Wyss R; Schneeweiss S; Merola JF
J Am Acad Dermatol; 2020 Jun; 82(6):1337-1345. PubMed ID: 32142748
[TBL] [Abstract][Full Text] [Related]
19. Treatment patterns and healthcare costs among biologic-naive patients initiating apremilast or biologics for the treatment of psoriatic arthritis: results from a US claims analysis.
Wu JJ; Pelletier C; Ung B; Tian M
Curr Med Res Opin; 2020 Jan; 36(1):169-176. PubMed ID: 31517542
[No Abstract] [Full Text] [Related]
20. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011.
Armstrong AW; Robertson AD; Wu J; Schupp C; Lebwohl MG
JAMA Dermatol; 2013 Oct; 149(10):1180-5. PubMed ID: 23945732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
